FOLD
Amicus Therapeutics
FOLD
FOLD
Delisted
FOLD was delisted on the 24th of April, 2026.
285 hedge funds and large institutions have $2.46B invested in Amicus Therapeutics in 2025 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 108 increasing their positions, 92 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2% more call options, than puts
Call options by funds: $9M | Put options by funds: $8.8M
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
2.45% less ownership
Funds ownership: 103.74% → 101.29% (-2.4%)
Holders
285
Holding in Top 10
4
Calls
$9M
Puts
$8.8M
Top Buyers
| 1 | +$33.4M | |
| 2 | +$31.2M | |
| 3 | +$27.6M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
+$20.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$16.2M |
Top Sellers
| 1 | -$22.5M | |
| 2 | -$21.2M | |
| 3 | -$17.7M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$15.3M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$12.6M |
